Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
75 1.3% |
 |
Gilead SciencesGILD |
52 3.7% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Apr 2025 | 29 | |
| Mar 2025 | 24 | |
| Feb 2025 | 15 | |
| Jan 2025 | 15 |
How do employees feel about the future at Novavax?
According to employees, the Business Outlook at Novavax is highly negative. This is reflected in the average rating of 27 out of 100, which is considered very low. This rating (aggregated from the top review sites in the US) is also down by -6.9% since the previous month.
Analyzing Business Outlook, how is Novavax performing compared to its industry peers?
Novavax underperforms its industry peers when it comes to Business Outlook, ranking in the 27th percentile.
How has the business outlook at Novavax changed over the last couple of months
In recent months, Novavax's employees have reported a shift towards a more positive business outlook, indicating improved company morale and potentially leading to increased market competitiveness and enhanced company performance.
Why is it important to track the business outlook at Novavax?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Novavax.
